TCA
TECH icon

Trifecta Capital Advisors’s Bio-Techne TECH Stock Holding History

Trifecta Capital Advisors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16
Closed -$891 – 428
2025
Q3 		$891 Sell
16
-9
-36% -$482 ﹤0.01% 418
2025
Q2 		$1.29K Buy
+25
New +$1.26K ﹤0.01% 399

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Trifecta Capital Advisors's TECH Position: Q4 2025 in Review

Trifecta Capital Advisors sold out of Bio-Techne (TECH) in Q4 2025, closing a stake of 16 shares — an estimated $891 sold.

Trifecta Capital Advisors first reported a position in TECH in Q2 2025 and held it in 2 quarters. The position peaked at $1.29K in Q2 2025. 585 funds tracked by Wall St. Rank hold TECH as of Q4 2025.

  • Trifecta Capital Advisors reported no remaining Bio-Techne position as of Q4 2025 after selling out during the quarter.
  • Trifecta Capital Advisors sold 16 Bio-Techne shares in Q4 2025, an estimated $891.
  • Trifecta Capital Advisors first reported a position in Bio-Techne in Q2 2025 and held it in 2 quarters.
  • Trifecta Capital Advisors's Bio-Techne position peaked at $1.29K in Q2 2025.
  • 585 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2025.

Based on Trifecta Capital Advisors's 13F filing for Q4 2025, filed 30 Jan 2026.